Registration
COVINGTON & BURLING LLP for AMARIN PHARMA INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
PDUFA: FDA special protocol assessment agreement process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOAN KUTCHER New | — |
| MUFTIAH MCCARTIN New | House Rules Committee, Staff Director (2009- ; ; 2010); House Rules Committee, Deputy Staff ; ; (Assistant 1991-2005); Clerk |
| WILLIAM WICHTERMAN New | Special Ass't to President Bush and Deputy Dir. ; ; Deputy Staff Director (2007-2008); House of |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| AMARIN CORPORATION, PLC | Ireland | United States | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.